Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.65 +0.01 (1.56%)
Previous Close $0.64    52 Week High $9.58 
Open $0.64    52 Week Low $2.34 
Day High $0.65    P/E N/A 
Day Low $0.62    EPS $-0.34 
Volume 263,042